Evaluation of the Link Between Carotid Arterial Wall Viscosity and Major Neurocognitive Disorders (VISCOG)

Evaluation of the Link Between Carotid Arterial Wall Viscosity and Major Neurocognitive Disorders of Vascular Origin or Linked to Alzheimer's Disease

The mechanical behavior of conductance arteries is viscoelastic. While the elastic component has been extensively studied, the viscous component has often been neglected for methodological reasons and also because it was considered weak.

Unlike a purely elastic solid, which exhibits instantaneous deformation/relaxation upon application/discontinuation of a force, a viscoelastic solid is characterized, from a mechanical point of view, by a delay between the application or discontinuation of the force and deformation. Thus, at the arterial level, the elasticity of the arterial wall allows the internal diameter to increase proportionally to the blood pressure during systole. The viscous component will induce a delay in diameter restoration, resulting in a larger diameter at each pressure level during the diastolic phase compared to the systolic phase. This results in a shift between the systolic and diastolic curves of the pressure-diameter relationship, creating a hysteresis loop. From a thermodynamic point of view, while a purely elastic material fully restores the energy stored during the loading phase, viscoelastic arteries will incompletely restore this energy. Thus, the surface of the hysteresis loop reflects the energy dissipated during each cardiac cycle (WV), and the area under the loading phase curve represents the energy stored by the arterial wall (WE) during the latter. Thus, arterial wall viscosity (APV) can be expressed either as the absolute value of WV or as a function of the stored energy (WV/WE). Physiologically, this energy loss is low. Its increase could be accompanied by excessive energy dissipation, leading to increased cardiac work and cardio-circulatory decoupling. Conversely, low parietal viscosity could lead to damage to peripheral organs by excessive transmission of pulsatile energy to the periphery due to lack of damping.

Study Overview

• Status: Recruiting
• Conditions: Neurocognitive Disorders; Alzheimer's Disease
• Intervention / Treatment: Diagnostic test: Assessment of carotid wall viscosity in patients with vascular dementia; Diagnostic test: Assessment of carotid wall viscosity in patients with Alzheimer's disease; Diagnostic test: Assessment of carotid wall viscosity in patients not presenting dementia.

Detailed Description

Preliminary work in the laboratories has highlighted the role of vaso-relaxing endothelial factors and smooth muscle tone in the regulation of the Arterial Pulse Rate (APR) of the radial artery in the basal and stimulated state and the alteration of this stimulated regulation during Arterial Hypertension (AH). Furthermore, a decrease in relative carotid APR in middle-aged subjects compared to young subjects, and an increase in carotid APR in diabetic patients has been found in unpublished results. The link between aortic arterial stiffness and the existence of vascular dementia but also Alzheimer's is strongly suggested. Indeed, the increase in arterial stiffness could be responsible for an increase in pulsatility transmitted to the brain, participating in the accumulation of beta amyloid proteins. A probable inflammatory and oxidative stress component could also have an added deleterious role through the production of free radicals. Thus, previous studies have shown the existence of a link between arterial stiffness and the presence of leukoaraiosis, lacunae, microbleeds but also with brain volume and the progression of cerebral atrophy. These repercussions on the cerebral parenchyma are visible on MRI.

A link has also been suggested between increased arterial stiffness and impaired cognitive function (as demonstrated by neurocognitive tests) or the presence of markers of small vessel damage in neuroimaging (microbleeds, lacunae, leukoaraiosis). One hypothesis to explain this link is that arterial stiffness promotes impaired hippocampal microcirculation. Other studies have shown that carotid-femoral pressure wave velocity (CFV), a marker of large arterial stiffness, was higher in populations with Alzheimer's disease and vascular dementia than in older populations without cognitive impairment or with minor neurocognitive impairment.

However, no studies have evaluated the link between baseline VPA and vascular dementia or Alzheimer's disease.

Our study suggests that carotid VPA is associated with increased cerebrovascular injury, impaired cognitive testing, and the diagnosis of vascular dementia.

• Study Type: Observational
• Enrollment (Estimated): 140

Contacts and Locations

• Study Contact: Name: Frédéric FR ROCA, Doctor; Phone Number: +33 02 32 88 05 39; Email: Frederic.Roca@chu-rouen.fr
• Study Contact Backup: Name: Philippe PC CHASSAGNE, Professor; Phone Number: +33 02 32 88 05 39; Email: Philippe.Chassagne@chu-rouen.fr

Study Locations

• France
  • Rouen, France, 76031
    • Recruiting
    • University Rouen Hospital
    • Contact: Frédéric FR ROCA, Doctor; Phone Number: +33 02 32 88 05 39; Email: Frederic.Roca@chu-rouen.fr

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Older Adult
• Accepts Healthy Volunteers: No

• Sampling Method: Probability Sample

Study Population

140 sujets dont 55 sujets avec démence vasculaire et 55 avec une démence de type maladie d'Alzheimer et 30 avec plainte mnésique sans troubles neurocognitifs.

Description

Inclusion Criteria:

• Age over 70
• Memory consultation consultant (neurology or geriatrics)
• Brain MRI less than one year old or planned as part of the cognitive assessment performed.
• Patient diagnosed with Alzheimer's disease according to DSM-5 criteria or vascular dementia according to DSM-5 criteria, or presenting a memory complaint without evidence of a dementia-related condition.
• No objection from the patient or their caregiver.
• Patient covered by a health insurance plan

Exclusion Criteria:

• Known unilateral or bilateral carotid stenosis or history of carotid surgery
• Permanent CA/AF
• Patient presenting with confusion
• Known psychiatric illness (severe depression, psychosis, etc.)
• Non-vascular, non-Alzheimer's dementia (e.g., Lewy Body Dementia, Parkinsonian Dementia, Progressive Supranuclear Palsy)
• Refusal to participate
• MMS less than or equal to 10
• Contraindication to performing an MRI
• Any acute decompensated pathology
• Patient under guardianship or curatorship

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Evaluation of the difference in relative arterial wall viscosity value of the common carotid artery of patients with vascular dementia compared to that of patients not presenting dementia	Carotid wall viscosity will be assessed using a method developed in the pharmacology department, involving simultaneous and continuous measurement by two operators of local pressure and diameter at the right and left carotid arteries, combining echotracking (Vevo 3100®) with applanation tonometry (Millar®). Three successive measurements will be performed. These measurements will establish the diameter-pressure relationship, and their analysis will allow calculation of wall viscosity by measuring the area under the curve of this relationship during the cardiac cycle. The primary outcome measure will be the difference in carotid arterial wall viscosity between the two groups of subjects; it will be studied by analysis of variance (ANOVA).	enrollment visit
Evaluation of the difference in relative arterial wall viscosity value of the common carotid artery of patients with vascular dementia compared to that of patients with Alzheimer's disease	Carotid wall viscosity will be assessed using a method developed in the pharmacology department, involving simultaneous and continuous measurement by two operators of local pressure and diameter at the right and left carotid arteries, combining echotracking (Vevo 3100®) with applanation tonometry (Millar®). Three successive measurements will be performed. These measurements will establish the diameter-pressure relationship, and their analysis will allow calculation of wall viscosity by measuring the area under the curve of this relationship during the cardiac cycle. The primary outcome measure will be the difference in carotid arterial wall viscosity between the two groups of subjects; it will be studied by analysis of variance (ANOVA).	Day 1

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Evaluation of the link between arterial parietal viscosity of the common carotid artery and the intensity of cerebral vascular	Establishment of the correlation between the relative arterial parietal viscosity value of the common carotid artery and the intensity of lesions in MRI (Fazekas Classification). The Fazekas classification is a system used in neurology and neuroradiology to assess and grade the severity of cerebral white matter lesions observed on MRI. (Low grades (0-1): Changes are often age-related and without major symptoms. High grades (2-3): Indicate more severe impairment, associated with a greater risk of cognitive impairment)	enrollment visit
Study of the link between arterial parietal viscosity of the common carotid artery and the severity of cognitive impairment (MMSE)	Measurement of the correlation between the relative arterial parietal viscosity value and cognitive performance score MMSE. This is a short, standardized test used to assess overall cognitive function (score 27-30 Normal cognitive function; score 21-26 Mild cognitive impairment; score 10-20 Moderate impairment; score <10 Severe impairment)	enrollment visit
Study of the link between arterial parietal viscosity of the common carotid artery and the severity of cognitive impairment (Gröber test)	Measurement of the correlation between the relative arterial parietal viscosity value and cognitive performance score Gröber test. This neuropsychological test assesses verbal episodic memory, that is, the ability to memorize and recall verbal information. This score quantifies an individual's cognitive performance on the Gröber Verbal Memory Test. The score reflects the individual's ability to learn, retain, and recall a list of words presented orally. This assesses the quality of short-term and long-term memory. (A high score indicates good verbal episodic memory. A low score may indicate memory impairment, such as in Alzheimer's disease, other forms of dementia, or following a traumatic brain injury.)	enrollment visit
Study of the link between arterial parietal viscosity of the common carotid artery and the severity of cognitive impairment (verbal fluency)	Measurement of the correlation between the relative arterial parietal viscosity value and cognitive performance score verbal fluency. Verbal fluency assesses cognitive ability, measuring how easily a person can produce words in response to a given instruction, often within a limited time. (High score = good word production ability, preserved cognitive functioning. Low score = lexical difficulties, executive dysfunction, or cognitive slowing.)	enrollment visit
Study of the link between arterial parietal viscosity of the common carotid artery and the severity of cognitive impairment (cognitive performance score (BREF))	Measurement of the correlation between the relative arterial parietal viscosity value and cognitive performance score (BREF). The Cognitive Performance Score (BREF) is a standardized measure used to assess a person's overall cognitive functioning. The score is given on a scale where a lower score indicates better cognitive performance, and a higher score reflects a more marked deficit.	enrollment visit
Study of the link between arterial parietal viscosity of the common carotid artery and the severity of cognitive impairment (score oral naming score (DO80))	Measurement of the correlation between the relative arterial parietal viscosity value and cognitive performance score oral naming score (DO80) carry out by assessing the ability to find and produce the exact name of an object (lexical denomination).	enrollment visit
Study of the link between arterial parietal viscosity of the common carotid artery and the severity of cognitive impairment (number of successful gestural praxis)	Measurement of the correlation between the relative arterial parietal viscosity value and the number of successful gestural praxis perform by measuring the ability to perform voluntary, coordinated and purposeful gestures, particularly learned or symbolic gestures (such as greeting, using a tool, making a sign)..	enrollment visit
link between arterial stiffness (carotid and aortic) and the intensity of cerebral vascular lesions in MRI	Measurement of the correlation between segmental arterial stiffness of the common carotid artery (modulus, distensibility) and the intensity of cerebral vascular lesions in MRI.	Enrollment visit
Link between arterial stiffness (carotid and aortic) and the intensity of cerebral vascular lesions in MRI as well as with the severity of cognitive impairment	Measurement of the correlation between segmental arterial stiffness of the common carotid artery (modulus, distensibility) and severity of cognitive impairment	enrollment visit

Collaborators and Investigators

• Sponsor: University Hospital, Rouen

Study record dates

Study Major Dates

• Study Start (Actual): February 15, 2022
• Primary Completion (Estimated): November 15, 2027
• Study Completion (Estimated): May 15, 2028

Study Registration Dates

• First Submitted: September 24, 2025
• First Submitted That Met QC Criteria: September 24, 2025
• First Posted (Actual): October 3, 2025

Study Record Updates

• Last Update Posted (Actual): May 22, 2026
• Last Update Submitted That Met QC Criteria: May 21, 2026
• Last Verified: January 1, 2026

More Information

Terms related to this study

• Keywords: carotid arterial wall viscosity
• Additional Relevant MeSH Terms: Mental Disorders; Neurocognitive Disorders
• Other Study ID Numbers: 2021/021/OB; 2021-A00291-40 (Other Identifier: ANSM)

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO
• IPD Plan Description: The data provided will be the property of the sponsor and will be used solely for its own research activities.

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No